About Guanine nucleotide-exchange factor SEC12
Guanine nucleotide-exchange factor SEC12 (PREB) is a protein
from Homo sapiens identified by UniProt accession
Q9HCU5, 417 residues long.
MolForge cross-references it against 0 known binders and
27 disease associations.
Target properties
| Protein name | Guanine nucleotide-exchange factor SEC12 |
| UniProt accession | Q9HCU5 |
| Gene | PREB |
| Organism | Homo sapiens |
| Length | 417 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (27)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.55
- cutaneous melanoma · score 0.14
- lung adenocarcinoma · score 0.12
- bilirubin measurement · score 0.02
- serum metabolite measurement · score 0.02
- infect · score 0.01
- infection · score 0.01
- fatty liver disease · score 0.01
- lung carcinoma · score 0.01
- acute lymphoblastic leukemia · score 0.01
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9HCU5-F1 | alphafold | PREDICTED | 88.09 | — |
Amino-acid sequence (417 residues)
MGRRRAPELY RAPFPLYALQ VDPSTGLLIA AGGGGAAKTG IKNGVHFLQL ELINGRLSAS LLHSHDTETR ATMNLALAGD ILAAGQDAHC QLLRFQAHQQ QGNKAEKAGS KEQGPRQRKG AAPAEKKCGA ETQHEGLELR VENLQAVQTD FSSDPLQKVV CFNHDNTLLA TGGTDGYVRV WKVPSLEKVL EFKAHEGEIE DLALGPDGKL VTVGRDLKAS VWQKDQLVTQ LHWQENGPTF SSTPYRYQAC RFGQVPDQPA GLRLFTVQIP HKRLRQPPPC YLTAWDGSNF LPLRTKSCGH EVVSCLDVSE SGTFLGLGTV TGSVAIYIAF SLQCLYYVRE AHGIVVTDVA FLPEKGRGPE LLGSHETALF SVAVDSRCQL HLLPSRRSVP VWLLLLLCVG LIIVTILLLQ SAFPGFL
Explore Guanine nucleotide-exchange factor SEC12 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets